MedPath

Efficacy of tREating aSymptomatic infEctions To resTore fERtility: The RESETTER Study

Phase 2
Not yet recruiting
Conditions
Infertility
Reproductive Health and Childbirth - Fertility including in vitro fertilisation
Registration Number
ACTRN12624001180505
Lead Sponsor
University of Western Australia
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Not yet recruiting
Sex
All
Target Recruitment
440
Inclusion Criteria

Aged 18 years + and attending either Concept Fertility or City Fertility clinics for investigation of unexplained infertility (unable to achieve clinical pregnancy after 12 months of regular unprotected sexual intercourse, where no other physiological or pathological diagnoses can explain this).

Exclusion Criteria

Currently pregnant, symptomatic genital tract infections, antimicrobial therapy within the past 14 days, known allergy to tetracycline or macrolide antibiotics.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change in the rate of clinical pregnancy at three months post-treatment in couples treated for Genital Mycoplasma colonisation.[Positive human chorionic gonadotropin urine analysis or blood test. Baseline (pre-treatment) and three months post-completion of treatment.]
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath